Welcome to our dedicated page for Lifeway Food news (Ticker: LWAY), a resource for investors and traders seeking the latest updates and insights on Lifeway Food stock.
Lifeway Foods, Inc. (NASDAQ: LWAY), the leading U.S. producer of probiotic kefir and fermented dairy products, provides this centralized hub for official company announcements and market developments. Investors and industry followers will find timely updates on financial results, product innovations, and strategic initiatives driving growth in the functional foods sector.
This resource aggregates all essential LWAY news, including quarterly earnings disclosures, manufacturing expansions, new product launches like probiotic-infused beverages, and distribution partnerships across domestic and international markets. Content is curated to help stakeholders track operational milestones and regulatory filings while maintaining compliance with financial disclosure standards.
Key news categories include financial performance updates, retail distribution agreements, R&D advancements in gut-health products, and sustainability initiatives. The archive serves as both a historical record and real-time tracking tool for Lifeway's position in the $50B global probiotic market.
Bookmark this page for streamlined access to verified Lifeway Foods updates. Combine these official releases with broader market analysis to inform your understanding of this innovative health-focused dairy producer.
Lifeway Foods (NASDAQ: LWAY) has announced the relaunch of its Basics Plus™ line of kefir and colostrum supplement shots, reviving a pioneering product from the late 1990s. The innovative beverage combines Lifeway's probiotic kefir with colostrum in a 3.5oz grab-and-go format, targeting both digestive and immune health support.
Originally introduced as America's first milk-based dietary supplement in grocery dairy cases, the product was ahead of its time. CEO Julie Smolyansky sees an opportunity to offer a higher-quality alternative to current probiotic shots, which often contain water, brown rice powder, and sugar. The relaunch comes as the global probiotic market is projected to reach $200 billion by 2030, with both kefir and colostrum experiencing significant growth in the health and wellness sector.
Lifeway Foods (NASDAQ: LWAY) has announced the expansion of its ProBugs® kefir line with new conventional whole milk pouches in three flavors. The products will be available nationwide in Creamy Orange, Goo-Berry, and Strawnana varieties. This launch follows the success of ProBugs' original 2007 debut as the first-ever pouched probiotic kefir for kids in the U.S.
The expansion aligns with strong market growth, as the global kids' yogurt pouch market reached USD 3.2 billion in 2024 and is projected to grow at a 6.1% CAGR to reach USD 5.47 billion by 2033. The new products aim to make gut health more accessible while maintaining the brand's signature probiotic benefits, protein content, and calcium in a convenient, kid-friendly format.
Lifeway Foods (Nasdaq: LWAY) reported exceptional Q2 2025 results with record net sales of $53.9 million, representing an 18% volume-led increase on a comparable basis. The company achieved significant milestones including gross margin expansion of 160 basis points year-over-year to 28.6% and net income of $4.2 million ($0.28 per share).
The momentum continues into Q3 2025, with unaudited net sales reaching $26.4 million through August 11, up over 20% year-over-year. July marked a historic achievement with the highest weekly sales ever recorded, exceeding $5.5 million. The company maintains its long-term target of $45-$50 million in Adjusted EBITDA for FY 2027.
Lifeway Foods (NASDAQ: LWAY) has announced the expansion of its distribution network through a partnership with Costco Wholesale in the San Diego region. The company will introduce its signature kefir products in 60 Costco locations across California, Arizona, Colorado, and New Mexico.
The offering includes a 12-count variety pack of 8oz bottles featuring strawberry and peach flavors. Each serving contains 10g of protein and 12 live & active probiotic cultures, with no artificial sweeteners or preservatives. The product is lactose intolerance-friendly and will be available in the refrigerated dairy section.
Lifeway Foods (NASDAQ: LWAY), a leading U.S. kefir supplier, announced its new 8oz Organic Flavor Fusions line has been nominated for the 2025 Dairy Product of the Year by Dairy Foods magazine. The innovative collection features 10 globally-inspired flavors, combining trending combinations like Matcha Latte and Pistachio Rose Vanilla with Lifeway's expertise in gut health.
The nomination follows Lifeway's recent recognition as Processor of the Year by Dairy Foods. CEO Julie Smolyansky highlighted how the product line merges popular flavor trends with the company's 40-year leadership in gut health. Public voting is open through August 31, 2025, with the winner to be announced in October 2025.
Lifeway Foods (NASDAQ: LWAY), a leading kefir and fermented dairy products supplier, has been awarded Dairy Foods Magazine's Processor of the Year for 2025. Under CEO Julie Smolyansky's leadership, who became the youngest female CEO of a public company in 2002, Lifeway has achieved significant milestones including record-breaking retail growth and innovative product launches.
The company's achievements include the introduction of Lifeway Probiotic Smoothie + Collagen and Flavor Fusions, implementation of sustainable manufacturing practices, and continued commitment to charitable initiatives. Lifeway will be featured in Dairy Foods' December 2025 issue and honored at the IDFA Dairy Forum in January 2026, as it approaches its 40th anniversary in 2026.
Lifeway Foods (NASDAQ: LWAY), a leading kefir and fermented probiotic products supplier, announced that Institutional Shareholder Services (ISS) has recommended shareholders "DO NOT VOTE" on the dissident-led consent solicitation by Ludmila and Edward Smolyansky.
ISS's analysis highlighted Lifeway's positive financial performance, noting significant outperformance against the Russell 3000 Food Producers Index peers. The report criticized the dissident group for lacking adequate context in their critiques and failing to present a clear governance or operational improvement plan.
CEO Julie Smolyansky welcomed ISS's recommendation, emphasizing that the consent solicitation is unwarranted and disruptive to shareholder interests.
Edward and Ludmila Smolyansky, controlling approximately 26% of Lifeway Foods (NASDAQ: LWAY), have provided an update on their consent solicitation process initiated on July 2, 2025. The shareholders are challenging the current board's actions, particularly criticizing the rejection of Danone's offer which represented a 72% premium over the 3-month volume weighted average price.
The Smolyanskys highlight several controversial board actions, including the adoption of a poison pill, delayed 2025 annual meeting, and a $8.5 million compensation package for CEO Julie Smolyansky. They're seeking shareholder support by August 1, 2025, to replace the incumbent directors and enable an independent evaluation of Danone's offer.
Lifeway Foods (Nasdaq: LWAY), a leading U.S. supplier of kefir and fermented probiotic products, has achieved a significant milestone by recording over $5.5 million in gross sales for the week ending July 13th, 2025. This represents a substantial 66% increase compared to the same period last year.
The company has scheduled to release its second quarter 2025 financial results on August 12, 2025 before market hours, accompanied by a pre-recorded conference call and webcast featuring CEO Julie Smolyanksy, which will be accessible through Lifeway's investor relations website.
Edward and Ludmila Smolyansky, who control approximately 26% of Lifeway Foods (NASDAQ: LWAY) shares, provided an update on their consent solicitation process initiated on July 2, 2025. The Smolyanskys are challenging the current Board's actions and seeking shareholder support to remove the existing board.
A key controversy emerged when Lead Independent Director Jason Scher sold 24,566 of his 24,567 shares at $24.23 per share, seemingly contradicting the Board's stance that Danone's $27 per share offer "severely undervalues" the company. This sale appears to violate the company's director stock ownership policy, which requires directors to maintain shares valued at 200% of their annual retainer.
The Board has claimed the consent solicitation is legally deficient, though the Smolyanskys note their formal request for a record date and shareholder list from June 17 remains unfulfilled.
FAQ
What is the current stock price of Lifeway Food (LWAY)?
What is the market cap of Lifeway Food (LWAY)?
